7/25
01:16 pm
vktx
Rating for VKTX
Medium
Report
Rating for VKTX
7/25
01:16 pm
vktx
Rating for VKTX
Medium
Report
Rating for VKTX
7/25
08:23 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
High
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
6/27
08:00 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $105.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $105.00 price target on the stock.
6/27
08:00 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $105.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $105.00 price target on the stock.
6/27
05:42 am
vktx
Rating for VKTX
Low
Report
Rating for VKTX
6/27
05:42 am
vktx
Rating for VKTX
Low
Report
Rating for VKTX
6/24
01:12 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
6/4
03:07 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "strong-buy" rating re-affirmed by analysts at Raymond James.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "strong-buy" rating re-affirmed by analysts at Raymond James.
6/4
03:07 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "strong-buy" rating re-affirmed by analysts at Raymond James.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "strong-buy" rating re-affirmed by analysts at Raymond James.
6/4
02:09 pm
vktx
Rating for VKTX
Low
Report
Rating for VKTX
6/4
02:09 pm
vktx
Rating for VKTX
Low
Report
Rating for VKTX
6/4
02:04 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $120.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $120.00 price target on the stock.
6/4
02:02 pm
vktx
Rating for VKTX
Low
Report
Rating for VKTX
6/4
10:06 am
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
5/16
02:12 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $116.00 price target on the stock, up previously from $115.00.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $116.00 price target on the stock, up previously from $115.00.
5/16
02:12 pm
vktx
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $116.00 price target on the stock, up previously from $115.00.
Low
Report
Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at Raymond James from an "outperform" rating to a "strong-buy" rating. They now have a $116.00 price target on the stock, up previously from $115.00.
5/16
01:58 pm
vktx
Rating for VKTX
Low
Report
Rating for VKTX
5/16
01:58 pm
vktx
Rating for VKTX
Low
Report
Rating for VKTX